Improving imaging techniques for diagnosing and evaluating hidradenitis suppurativa
Official title: Combined Photoacoustic and Ultrasound Imaging for Enabling Quantitative Evaluation of Hidradenitis Suppurativa
Funded at University of Illinois at Chicago · NIH-11056755 · Data updated 2026-11-12
This study is looking to improve how we diagnose and plan treatment for hidradenitis suppurativa (HS) by using new imaging techniques that can spot important signs of the condition that regular methods might miss, helping patients find better treatments faster.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project start | March 15, 2024 |
| Project end | January 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $603,461 |
| NIH project number | 5R01AR083470-02 |
| Project ID | NIH-11056755 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with hidradenitis suppurativa who are seeking better management options for their condition.
✕Less likely to help
Patients without a diagnosis of hidradenitis suppurativa or those who do not experience significant symptoms may not benefit from this research.
What this research studies
This research focuses on enhancing the diagnosis and treatment planning for hidradenitis suppurativa (HS), a painful skin condition affecting millions. By combining photoacoustic and ultrasound imaging, the study aims to provide a more accurate evaluation of HS by detecting biomarkers that are not visible through traditional methods. Patients will benefit from improved imaging techniques that can lead to better treatment outcomes and reduced time spent searching for effective therapies. The research team includes experts in imaging and dermatology who have gathered input from various specialists to ensure the imaging system meets clinical needs.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients suffering from hidradenitis suppurativa.
How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for other chronic inflammatory conditions, suggesting potential success for this novel approach.
Where this research is happening
-
University of Illinois at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Avanaki, Kamran — University of Illinois at Chicago
- Study coordinator: Avanaki, Kamran
Related research
Other NIH-funded projects on the same topics.
-
Photoacoustic and ultrasound imaging to better measure hidradenitis suppurativa
This project tries a new imaging method that combines photoacoustic and ultrasound scans to better see and measure disease in people with hidradenitis suppurativa.
-
Modulating deep brain activity with focused ultrasound for cocaine use disorder
A study will test whether targeting a deep brain region with focused ultrasound can alter brain signals related to craving in people with cocaine use disorder.
-
Dose-Dependent Brain Wire Modulation with Light Ultrasound in Deep White Matter
A small early study tests whether gentle, noninvasive ultrasound can change how deep brain white matter tracts work in healthy adults.
-
Ultrasound-guided brain circuit targets for treatment-resistant depression
This grant tests whether focused ultrasound can safely and reversibly adjust brain circuits linked to negative mood in people with treatment-resistant depression.
-
Ultrasound biomarkers to diagnose and predict treatment response for plantar heel pain
A study will test advanced ultrasound imaging to find biomarkers that help diagnose plantar heel pain and predict who will respond to targeted treatments.
-
Brain ultrasound and microcirculation to understand early brain development in HIV-exposed uninfected infants
We’re studying how brain ultrasound and blood flow patterns in newborns exposed to HIV and antiretroviral drugs (but not infected) relate to their early neurodevelopment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.